Bakuchiol

Bakuchiol is a meroterpene phenol from the seeds of Psoralea corylifolia. It is marketed as a retinol alternative, and the interesting scientific point is that the comparison is functional rather than structural — a claim that is unusual enough to be worth examining rather than repeating.

Structurally it has nothing to do with retinol

Retinoids share a defined architecture: a cyclohexenyl (β-ionone) ring, a conjugated polyene chain, and a polar end group — an alcohol in retinol, an aldehyde in retinal, a carboxylic acid in retinoic acid. That polyene chain is what makes retinoids both biologically active and notoriously unstable to light and oxygen.

Bakuchiol has none of it. It is a phenol with a monoterpene-derived side chain: no ring of that kind, no extended polyene, no carboxyl.

So bakuchiol cannot be a retinoid by structure, and any claim that it “acts like retinol” has to be a claim about downstream biology, not about chemistry.

What the comparison actually rests on

The substantive evidence is transcriptomic. Gene-expression profiling in skin models found that bakuchiol regulates a set of genes overlapping substantially with those regulated by retinol — including upregulation of collagen types I, III and IV and modulation of matrix metalloproteinases, the enzymes that degrade dermal collagen.

That is a real and specific finding, and it is the honest basis of the category. It is also weaker than it is usually made to sound. Overlapping downstream gene expression does not establish a shared mechanism, and how bakuchiol produces the effect is unresolved. Whether it engages retinoic acid receptors at all is disputed; several lines of evidence suggest it does not, which would make the resemblance convergent rather than mechanistic.

The clinical evidence is one small randomised comparison against retinol reporting comparable improvement in photoageing measures with less irritation, plus a handful of further small studies. That is a thin base for a strong claim, and the appropriate summary is that bakuchiol shows retinol-like activity in gene-expression and early clinical work, with the mechanism unknown and the trial base small.

Where it has a genuine physical advantage

Two properties are not in dispute and both follow from structure.

Photostability. Retinol’s conjugated polyene is a chromophore, so it absorbs light and degrades — which is why retinol products are packaged opaque and airless and are advised for night use. Bakuchiol has no such chromophore and is markedly more stable to light and oxygen. This is a formulation advantage that requires no biology to justify.

Irritation. Retinoid irritation — erythema, peeling, stinging — is mechanistically tied to retinoic acid receptor activation and the resulting changes in keratinocyte differentiation. If bakuchiol is not acting through those receptors, lower irritation is the expected consequence rather than a coincidence.

The source question that matters

Psoralea corylifolia also contains psoralens — furocoumarins that are potent photosensitisers, used clinically precisely because they cause phototoxic reactions on UV exposure.

Bakuchiol is not a psoralen and does not carry that liability itself. But a plant extract can, and the risk is one of purity rather than identity. This is the strongest argument for a fermentation-derived or fully synthetic bakuchiol: it removes the co-extractive question entirely, rather than managing it by specification.